Shenzhen Meizhonglian showcases e-cigarette products in Germany exhibition

Sep.15.2022
Shenzhen Meizhonglian showcases e-cigarette products in Germany exhibition
The 2022 Dortmund Tobacco Exhibition opened on September 15th with Shenzhen Meizhonglian Technology showcasing their products.

On September 15th, 2022, the German Dortmund Tobacco Exhibition opened with great fanfare. The exhibition covers an area of ​​13,500 square meters, with a record number of 12,000 visitors and features 475 exhibitors showcasing their brands.


Shenzhen Meizhonglian Technology Co., Ltd. is located at booth 1.A28, packed with people. Under the direction of Jason, the diplomatic assistant of the Electronic Cigarette Professional Committee of the China Electronic Commerce Association (ECCC), and the public relations manager of 2FIRSTS, onsite staff explained products to attendees, connected with Meizhonglian employees in China, and exchanged contact information.


At the exhibition, Meizhongli presented its superior technological products and latest research results in all aspects. Its fascinating product introduction and innovative exhibits drew the attention of the participating audience. Meizhongli's leaders expressed that Europe is a very potential and representative market, and this exhibition provided a broad platform for Meizhongli to showcase its representative products, deepen the participants' impression of Meizhongli, and help boost the brand's future business expansion and product development.


As a Chinese company that holds strategic partnerships with numerous internationally renowned brands and multinational tobacco companies, Shenzhen Meizhonglian Technology Co., Ltd has overcome various uncertainties brought about by the global COVID-19 pandemic and geopolitical landscape to participate in this significant tobacco exhibition. Through this event, the company gained a better understanding of industry trends, showcased the strength of China's electronic cigarette industry to the international community, and enhanced its brand influence.


Founded in Shenzhen in 2019, Meizhonglian is one of the high-tech companies focused on researching and applying electronic atomization technology. The company has gradually established an international business system with China as its research and manufacturing center, and products and services that radiate globally. Meizhonglian currently has research and development teams in the United States and China, and has established a new materials research institute and high-end laboratory in cooperation with a US-listed company. With a modern manufacturing center of over 10,000 square meters and a peak production team of 1,500, Meizhonglian is dedicated to supporting global original equipment manufacturers and manufacturers' projects.


US United Coalition showcases products at this exhibition.


Under the leadership of Chairman Shi Jinglian, Meizhong United was founded in 2015. In 2016, it began researching and developing factory processing, and by the end of 2018, the company had achieved its goal of independent research and development production. According to Shi Jinglian, Meizhong United's ability to guarantee product sales in just a few years is mainly due to the establishment of high standards, research into new technologies, and good partnerships.


In order to attract more environmentally conscious e-cigarette consumers in Europe, Meizhonglian has put forward an environmental concept to attract local brands and to further explore the concept. Eventually, this will result in a systematic demonstration of environmental solutions to customers.


美众联展示了在本次展会上的海报" (Meizhonglian displayed their poster at this exhibition)


The head of the company delegation stated that they gained a lot from participating in the trade show. The event was held offline as a major industry event since the outbreak of the pandemic worldwide. As a Chinese corporation attending the exhibition, Meizhonglian had a strong lineup and showcased a variety of highlights, gaining extensive attention from the industry and achieving a good outcome. It is believed that Chinese electronic cigarette companies will surely have great potential in the international market in the future.


To read more about the latest news and updates on the Dortmund tobacco exhibition in Germany, please click on the link below.


1. This article is intended solely for industry discussion and communication and does not serve as a promotional or endorsement platform for any particular brand or product. 2. Smoking is detrimental to one's health. Minors are prohibited from reading this article.


This article is an original piece from Shenzhen 2FIRSTS Technology Co., Ltd. The copyright and permission to use belong to the company, and no individual or organization may reproduce, reprint, or use in any unauthorized manner that violates the company's copyright without permission. The company reserves the right to pursue legal action against any violators.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
The House-passed FY2027 National Defense Authorization Act includes a provision authorizing the defense secretary to conduct a one-year smoking-cessation pilot for active-duty service members. Section 707 lists counseling, nicotine gum and patches alongside what the bill calls "electric nicotine delivery systems," nicotine pouches and heat-not-burn products. A recent Washington Examiner op-ed cited ZYN as an example in arguing for the provision, but the legislation does not name any commercial brand or supplier. ZYN is made by PMI-owned Swedish Match USA, with specified products holding FDA marketing authorizations and modified risk orders.
Sep.20
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia’s withdrawal of its appeal in a landmark liquid-nicotine case has left a High Court ruling that struck down the 2023 nicotine exemption in force, bringing liquid and gel nicotine used in vaping products back under the Poisons Act 1952. At the same time, the Control of Smoking Products for Public Health Act 2024 continues to provide a regulatory framework for vaping products, creating uncertainty over retail sales, taxation and existing inventory. MPs are calling for nicotine vape sales and excise collection to stop, including refunds of more than RM354 million collected since 2023, while industry and consumer groups are asking the government to clarify the current legal position.
Sep.04
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
Swedish-Founded Nicotine Pouch Retailer GotPouches Shifts to U.S.-Based Operations, Reaching Over 25 States
Swedish-Founded Nicotine Pouch Retailer GotPouches Shifts to U.S.-Based Operations, Reaching Over 25 States
Swedish-founded online nicotine pouch retailer GotPouches has completed the localization of its U.S. operations under UpNorth Retail LLC, with corporate operations in Franklin, Tennessee, domestic fulfillment from Nashville and U.S.-based customer support. The company says its catalog covers more than 20 nicotine pouch brands and it currently serves customers in more than 25 U.S. states.
Sep.18
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25